Adler Reid G. 4
4 · VistaGen Therapeutics, Inc. · Filed May 3, 2022
Insider Transaction Report
Form 4
Adler Reid G.
Chief Legal Officer
Transactions
- Award
Stock Options (right to buy)
2022-05-02+200,000→ 200,000 totalExercise: $1.28Exp: 2032-05-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the stock options vest on May 2, 2023 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.